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UNIT A11.2Cardiac Masses
Although echocardiography is considered the primary technique for evaluating cardiac
masses, magnetic resonance imaging (MRI) may be indicated in patients who have poor
acoustic windows or in whom lesions are incompletely characterized by echocardiogra-
phy. This unit presents the basic technique for evaluating cardiac masses, with optional
contrast-enhanced sequences for specific indications. The parameters are based on
experience on a Siemens 1.5 T Vision or Symphony and should be altered accordingly
for different field strengths and manufacturers.
BASIC
PROTOCOL
IMAGING OF CARDIAC MASSES
To image the heart, cardiac imaging packages that allow gated fast imaging of the heart
using echo-train fast (or turbo) spin-echo and segmented k-space cine gradient-echo
images are necessary for better imaging with examination times that are practical in the
clinical setting.
Similar to that described for pericardial disease in UNIT A11.1, the core components of the
imaging protocol are gated T1-weighted and T2-weighted turbo spin-echo images and cine
gradient-echo images through the heart. The spin-echo images are used to provide
high-resolution multiplanar imaging of the heart and to help to characterize masses. A
fat-suppressed imaging sequence is optional for suspected germ cell tumors, lipomas, or
lipomatous hypertrophy of the interatrial septum. The two-dimensional electrocardio-
gram (2-D ECG)–gated cine gradient-echo images provide views of a single slice at
multiple phases of the cardiac cycle. When viewed in the cine mode, images can be used
to evaluate the motion of the heart dynamically. Cine MRI can help distinguish a mass in
a cardiac chamber from flowing blood and also is useful for evaluating physiologic effects
of masses, such as mitral valvular obstruction by a left atrial myxoma. With fast
breath-hold cine acquisitions, the total examination time for the Basic Protocol should be
<45 min.
For patients with certain entities, such as thrombus versus mass or suspected intramural
tumors, additional contrast-enhanced imaging of the heart can be performed by repeating
T1-weighted imaging following intravenous gadolinium contrast material.
Table A11.2.1 lists the hardware necessary to perform MRI of the heart. Higher gradient
strengths with imaging sequences that allow gated turbo spin-echo and segmented cine
gradient-echo imaging are preferable.
Materials
Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
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Table A11.2.1 Equipment Parameters for Pericardial Imaging
Coil type Torso phased-array coil (or dedicated cardiac
coil, if available)
Gradient coil strength 25–40 mT/m (or whatever the system permits)
Cardiac gating Yes, preferably fiber-optic cables
Peripheral gating No
Oxygen Yes, 2 liters nasal cannula for most patients (to
ensure breath-holding >15 sec)





Set up equipment and patient
1. As discussed in UNIT A11.1 on pericardial disease, it is important to interview and screen
the patient to ensure that he or she has no contraindications such as cardiac pacemaker
or defibrillator or other ferromagnetic materials near vital structures. Also, ensure
that the patient does not have health conditions, including those related to cardiac or
pericardial disease, that may require emergency equipment during the scanning
procedure.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, ask the patient to wear these, but inform the patient
that he or she will be able to communicate with you at any time during the imaging.
b. Give the patient a safety squeeze-bulb or similar equipment to request assistance
at any time (demonstrate how this works).
c. For good results inform the patient not to talk and to avoid or minimize swallowing
or other movement, during each scan—i.e., as long as the banging sounds continue.
Between scans, talking and swallowing are allowed in most cases but should be avoided
when comparative positional studies are being performed; the patient will be informed
when this is the case.
d. Inform the patient that, if necessary, he or she may call out at any time.
5. Inform the patient of the need to hold his or her breath (preferably at end expiration)
for ∼15 to 20 sec for each cine gradient-echo acquisition. Assess need for supplemen-
tary oxygen to improve breath-holding capacity, and if necessary, administer 2 liters
oxygen via nasal cannula. Advise the patient of the importance of not moving during
the acquisition periods and of not taking deep breaths during the non-breath-hold
acquisitions.
6. When the patient is on the table, place MRI-compatible ECG leads (Quatrode from
In Vivo) according to manufacturer’s guidelines. When possible, place leads on the
back as this may reduce motion artifacts related to breathing. Make sure that the ECG
tracing resulting from the lead placement results in high (positive) R waves. If it does
not, either reposition the leads or toggle the lead polarity to alternative options, if
available on the system.
7. Place a pillow or other support under the knees to make the patient more comfortable.
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8. Place a 22-G intravenous catheter in the antecubital fossa if the gadolinium contrast
is deemed likely to be necessary.
A power injector can be used to administer contrast, but it is not necessary.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion, between the scans run before contrast agent injection and those
run after injection.
9. Center the patient’s chest in the phased-array coil.
10. Use the centering light to position the patient and put him or her into the center of
the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
11. If the patient is unable to hold still, provide an appropriate sedative.
12. Once the patient has been centered in the magnet, check again to be sure that the ECG
tracing demonstrates sharp positive R waves for suitable triggering. If not, then, with
patient still positioned within the magnet, toggle lead polarity until a suitable tracing
is obtained. If this is still not satisfactory, then bring the patient out of the magnet,
check lead connections, and if necessary, reposition leads until a satisfactory tracing
is obtained.
Sequence 1: Rapid three-plane positioning scout
13. For localization of subsequent acquisitions, run the system’s three-plane scout scan
(see Table A11.2.2). If possible, have the patient breath-hold at end expiration for the
scout to better positioning of subsequent acquisitions.
Sequence 2: 2-D transverse double inversion recovery half-Fourier single-shot turbo
spin echo (db-HASTE)
14. Use this ultrafast turbo spin-echo sequence (Table A11.2.3) with blood-nulling
preparatory pulse for an overview of the heart to localize lesions for subsequent
spin-echo imaging. Position a series of transverse slices off the scout images to ensure
coverage of the entire heart.
This is a T2-weighted sequence, and most tumors will appear high in signal intensity on
HASTE.
The sequence can be performed with breath-holding at end expiration, but this is not
absolutely necessary.
ECG-gating, also not necessary, can be used for improved images.
Sequence 3: 2-D transverse T1-weighted turbo spin-echo (TSE)
15. Use the pilot scan and HASTE images to locate the mass in question or to define the
extent of the cardiac abnormality. For greater coverage, run this sequence twice using
the parameters shown in Table A11.2.4. If the area of coverage can be localized (e.g.,
for evaluation of a mass), only perform the sequence once with minimum slice gap
(Fig. A11.2.1).
For T1 weighting, TR should be ∼85% to 90% of the patient’s R-to-R interval (time between
R waves) and <900 msec. Short TR times will limit the number of slices that can be obtained
in each acquisition.
16. Because acquisition times are too long to allow breath-hold imaging, with multiple
acquisitions, instruct the patient to perform shallow breathing.




Table A11.2.2 Primary Clinical Imaging Parameters for Sequence 1 (Pilot
Scan)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Three-plane (transverse, coronal,
sagittal)
Central slice or volume center Center of chest
Echo time (TE) As short as possible
Repeat time (TR) As short as possible
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 500 mm, 500 mm
Resolution (∆x, ∆y) 1.95 mm, 3.91 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 5–10
Slice gap 0–10
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses Not applicable
Scan time 5–15 sec
Table A11.2.3 Primary Clinical Imaging Parameters for Sequence 2 (HASTE)
Patient position Supine
Scan type Single-shot fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Center of heart
Echo time (TE) 43–63 msec (effective)
Repeat time (TR) Infinity (echo spacing is ∼4 msec)
Delay time (TD) 700 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 300–350 mm, 300r–350r mm,
with r = 3/4 (rectangular field of
view) depending on body habitus
Resolution (∆x, ∆y) 1.17–1.37 mm, 1.70–1.99 mm
Number of data points collected (Nx, Ny) 256, 176r, with r = 3/4
(rectangular field of view)
depending on body habitus
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5–8 mm
Number of slices 20
Slice gap 0.8–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses No
ECG gating Not necessary
Scan time 20–30 sec
aThe system displays the flip angle of the refocusing pulse.
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Sequence 4: 2-D fat-suppressed transverse T2-weighted inversion-recovery turbo
spin echo (optional)
17. Perform limited transverse T2-weighted turbo spin-echo images through the heart as
needed.
An inversion-recovery technique will provide useful fat suppression and allow charac-
terization of fatty masses, such as lipomas of the heart (Fig. A11.2.2).
18. Set the imaging parameters as shown in Table A11.2.5 to obtain a single slice per
breath-hold. Instruct the patient to breath-hold at end expiration, if possible, for best
reproducibility.
The TR plus delay time should be <85% to 90% of two R-to-R intervals.
19. Adjust the inversion time depending on the particular manufacturer. Select delay
times to allow imaging in diastole.
The inversion time determines the degree of fat suppression obtained.
Table A11.2.4 Primary Clinical Imaging Parameters for Sequence 3
(T1-Weighted TSE)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Center of heart
Echo time (TE) 12 msec (or minimum)
Echo train length (ETL) 3
Repeat time (TR) <900 msec (and <90% of the
R-to-R interval)
Delay time after R wave 0 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 300–350 mm, 300r–350r mm,
with r = 3/4 (rectangular field of
view) depending on body habitus
Resolution (∆x, ∆y) 1.17–1.37 mm, 1.43–1.67 mm
Number of data points collected (Nx, Ny) 256, 210r, with r = 3/4
(rectangular field of view)
depending on body habitus
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 4–8 mm
Number of slices 10–12
Slice gap 0.4 to 0.8 mm or 4–8 mm if
concatenatedb
Number of acquisitions (Nacq) 3–5
Swap read and phase encoding No
Saturation pulses No
ECG gating Yes
Scan time 3–8 min
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
bIf the z-axis coverage needed is on the order of 60 to 80 mm, then a single acquisition with about 8
to 10 slices at 6 to 8 mm thickness and minimal gap (0.6 to 0.8 mm) can be performed. For complete
coverage of the chest, two separate acquisitions of 8 to 10 slices can be performed, each with a gap
equal to the slice thickness (e.g., 8 mm slice thickness with 8 mm gap). In this example, the second
acquisition should be performed with the slice positions shifted by 8 mm and with the same thickness
and gap, so that with the two acquisitions together, complete coverage of the chest will be obtained
with 8-mm-thick slices and effectively no gap.





Figure A11.2.1 Left atrial myxoma. (A) Transverse T1-weighted turbo spin echo and (B) trans-
verse cine gradient echo show a large mass in the left atrium (M).




Figure A11.2.2 Atrial lipoma. (A) Transverse HASTE image and (B) transverse short TI inversion-
recovery image through the right atrium demonstrate a large mass in the right atrial wall (curved
arrows) and also involving the interatrial septum (shorter arrowhead in A). The lesion is high in
signal intensity on the HASTE image. The loss of signal intensity in the mass on the inversion-re-
covery sequence parallels that of subcutaneous fat and supports the diagnosis of right atrial lipoma
with involvement of the internal septum.




Sequence 5: 2-D transverse and coronal fast cine gradient echo
20. Generally, perform transverse cine gradient-echo imaging, slice by slice, through the
entire heart. Obtain additional coronal or sagittal oblique views for evaluation of
specific regions, for example, through the inferior vena cava for evaluation of vascular
extension of tumor thrombus from hepatoma or renal cell carcinoma.
Cine gradient-echo images can be performed selectively. A four-chamber view or two-
chamber view of the heart may be useful to determine whether an atrial mass interferes
with mitral or tricuspid valvular function.
21. Set the imaging parameters as shown in Table A11.2.6 to obtain a single slice per
breath-hold. Adjust the parameters depending on the patient’s breath-holding capa-
bility and heart rate. For patients with slower heart rates, use sequences that provide
a greater number of lines per segment to help reduce acquisition times. Set the number
of phases of the cardiac study according to the formula:
Number of cardiac phases = (R-to-R interval) × 85%/TR
Parameters shown in Table A11.2.6 are for a segmented k-space approach with nine lines
of k-space per segment and four echoes shared.
22. Instruct the patient to breath-hold at end expiration, if possible, for best reproduci-
bility. If patient is unable to breath-hold, perform the sequence with multiple
Table A11.2.5 Primary Clinical Imaging Parameters for Sequence 4 (Short Tau
Inversion Recovery, Optional)
Patient position Supine
Scan type Inversion recovery fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Center of heart
Echo time (TE) 57–76 msec
Echo train length (ETL) 33
Repeat time (TR) <900 msec [TR + TD should be <2
× (85% to 90%) × (R-to-R
interval)]
Inversion time (TI) 170 msec
Delay time (TD) 500 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 300–350 mm, 300r–350r mm,
with r = 3/4 (rectangular field of
view) depending on body habitus
Resolution (∆x, ∆y) 1.17–1.37 mm, 1.67–1.94 mm
Number of data points collected (Nx, Ny) 256, 180r, with r = 3/4
(rectangular field of view)
depending on body habitus
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8 mm
Number of slices 1
Slice gap Not applicable
Number of acquisitions (Nacq) 1
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acquisitions (three-signal averages, for example) with the patient breathing normally
or shallowly.
Sequence 6: 2-D transverse T1-weighted turbo spin echo (optional)
For patients with specific clinical indications, such as the differentiation between cardiac
tumor and thrombus or suspected intramural masses, contrast-enhanced images may also
be needed.
23. Leaving the patient in the magnet, inject the contrast agent, flush the line with 20 ml
saline.
Intravenous gadolinium contrast material at a dose of 0.1 mmol/kg is administered and
turbo T1-weighted spin-echo images repeated. Non-enhanced images can be subtractedfrom contrast-enhanced images using post-processing software to depict enhancing le-
sions.
24. Repeat the sequence described in Table A11.2.4, ensuring that all imaging parameters
are kept the same to facilitate post-processing.
COMMENTARY
Background Information
The primary screening test for suspected
intracardiac masses is transthoracic echo-
cardiography. However, there are limitations
with this technique. The limited field of view,
dependence on adequate acoustic window and
skill of the echocardiographer, and limited
visualization of certain areas of the heart such
Table A11.2.6 Primary Clinical Imaging Parameters for Sequence 5 (Cine
Gradient Echo)
Patient position Supine
Scan type Segmented k-space cine gradient
echo
Imaging plane (orientation) Transverse (coronal is optional)
Central slice or volume center Center of heart
Echo time (TE) 4.8 msec (or minimum)
Number of lines per segment 9 (see step 21)
Repeat time (TR) 80–100 msec (temporal resolution)
Delay time (TD) 0 msec
Flip angle (FA) 20°
Fields of view (FOVx, FOVy) 300–350 mm, 300r–350r mm,
with r = 3/4 (rectangular field of
view) depending on body habitus
Resolution (∆x, ∆y) 1.17–1.37 mm, 1.70–1.99 mm
Number of data points collected (Nx, Ny) 256, 176r, with r = 3/4
(rectangular field of view)
depending on body habitus
Display matrix (Dx, Dy) 256, 256
Slice thickness 5–7 mm
Number of slices 1
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses No
Number of cardiac phases (R-to-R interval) × 85%/TR
ECG gating Yes
Scan time 15–20 sec




as the apex or left atrial appendage require
additional performance of transesophageal
echocardiography in many cases, which is in-
vasive and also limited in field of view (Martin
et al., 1998). Magnetic resonance imaging can
provide a noninvasive yet comprehensive
anatomic and physiologic assessment of car-
diac masses by relying on spin-echo imaging
for anatomy and cine gradient-echo imaging
for flow and function.
The most common cardiac mass is throm-
bus, which typically lies in a dilated left atrium
or ventricle. Thrombus can usually be distin-
guished from most neoplastic masses by mor-
phology and the lack of contrast enhancement.
Benign tumors include myxomas, typically
arising in the left atrium with a pedicle attached
to the atrial septum, and lipomas, usually in the
right atrium as a discrete mass or more com-
monly a uniform fatty infiltration of the intera-
trial septum (Fig. A11.2.2). Lipomas can be
characterized by using fat suppression se-
quences to identify the presence of fat within
lesions. In children, rhabdomyomas can be
found, typically within the ventricles, and are
associated with tuberous sclerosis. Malignant
tumors are most commonly secondary, such as
direct extension from adjacent lung or medi-
astinal malignancies, vascular extension from
renal cell carcinoma or hepatoma, or hemato-
genous metastases, such as melanoma or sar-
coma. Primary cardiac malignancies are ex-
tremely rare, the most common being angiosar-
coma (Higgins, 1992). Unlike benign tumors,
malignancies of the heart typically are less
well-circumscribed and demonstrate aggres-
sive infiltrative appearance, best seen on con-
trast-enhanced images. Magnetic resonance
imaging can also help to differentiate cardiac
masses from adjacent paracardiac pathology




As discussed in UNIT A11.1 on pericardial im-
aging, ECG tracings are vital for all imaging of
the heart. Sharp up-going R waves with signifi-
cantly smaller (or inverted) T waves are needed
since triggering typically depends on the ECG
value crossing a particular threshold. Magnetic
resonance–compatible ECG leads with con-
ductive gel should be used. For good skin con-
tact, the patient’s skin may need to be shaved.
The position of the heart and axes of the con-
duction pathways may vary considerably
across patients. The manufacturer’s recommen-
dations of lead positioning should be used as a
starting point. If polarity is not as desired (e.g.,
inverted R waves), check that leads are posi-
tioned correctly (RA to the right side, LA to the
left side, etc), and then, if needed, toggle
through the lead polarity options (I, II, AVR,
etc.). Finally, as a last resort, reposition ECG
leads, using new adhesive pads to ensure ade-
quate adhesion and conduction gel. If ECG
tracings are lost during positioning of the pa-
tient or scanning, check the patient to ensure
that leads have remained properly connected.
Customization of gated MRI parameters
Magnetic resonance imaging of the heart
and pericardium requires careful customization
of imaging parameters according to patient
heart rate and breath-holding capability (see
UNIT A11.1 on pericardial imaging). For a multi-
slice turbo spin-echo sequence, the number of
slices that can be imaged in one acquisition
depends on the TR, which in turn depends on
the patient’s heart rate. For single-slice cine
gradient-echo images, multiple phases of the
heart cycle are imaged at a single slice position.
The more lines of k space (number of phase-en-
coding lines) that are collected for each cardiac
phase during each TR interval, the faster the
acquisition time, but fewer cardiac phases can
be acquired. While sequences could be custom-
ized for every patient, to simplify the process,
system protocols should be set up for specific
categories of patients, such as “slow heart rate”
and “fast heart rate” with the aim of limiting
acquisition times <20 sec.
On some systems, a view-sharing option
will be available for cine gradient-echo se-
quences that enables almost double or greater
temporal resolution (number of cardiac phases)
in the same acquisition time.
Motion or breathing artifacts
Cine gradient-echo images can be per-
formed with multiple signal averages when
patients are unable to breath-hold adequately.
Supplemental oxygen via nasal cannula can
improve a patient’s breath-holding capability
substantially and should be considered in all
patients.
Imaging infants and children
MR imaging techniques must be modified
for the evaluation of suspected masses in infants
and children. A head coil should be used for
small infants. Non-breath-hold modifications
such as multiple signal averages should be used.
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Appropriate sedation should be administered
when necessary.
Pseudotumors
In ∼59% to 90% of patients, a nodular or
linear density can be seen along the posterior
wall of the right atrium (Mirowitz and Gutier-
rez, 1992; Meier and Hartnell, 1994). This
characteristic lesion can be misinterpreted as
an intracardiac mass and cause potential diag-
nostic difficulties if unrecognized. The mass is
caused by normal fibromuscular elements of
the right atrium, such as the crista terminalis
and Chiari network (Fig. A11.2.3).
Anticipated Results
The goal of MRI of the cardiac masses is to
localize and characterize as best possible
masses within the heart. With adequate ECG
gating, MRI can provide clear visualization of
anatomic abnormalities (Fig. A11.2.1) as well
as an assessment of consequent hemodynamic
abnormalities. Magnetic resonance imaging
can be used to characterize lipomas and lipo-
matous hypertrophy of the interatrial septum
(Fig. A11.2.2). Vascular or adjacent extension
of tumor into the heart can be visualized be-
cause of the large field of view available with
MRI.
Contrast material can supplement cine gra-
dient-echo imaging in helping to differentiate
nonenhancing masses such as thrombus from
neoplastic disease. However, in many cases,
contrast material is not needed to diagnose and
characterize cardiac masses.
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